Amar, US
Amar Chand Amar, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20130142329 | UTILIZING PHYSICALLY UNCLONABLE FUNCTIONS TO DERIVE DEVICE SPECIFIC KEYING MATERIAL FOR PROTECTION OF INFORMATION - A device specific key is generated within an electronic device by providing a challenge to a physically unclonable function (PUF) structure integrated within the electronic device, where the PUF structure outputs a specific response based upon a specific challenge provided to the PUF structure. The PUF response is provided to a cryptographic module integrated within the electronic device, and a device specific key is generated by the cryptographic module utilizing a cryptographic key generation algorithm. The device specific key is generated based upon a combination of input data including the PUF response and data that is specific to the electronic device. | 06-06-2013 |
Anshul Amar, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20090192821 | Medical image annotation - Incorporating new technology into an existing medical practice is often difficult. Documents associated with a patient, for example, a patient's medical charts, are typically provided physically, i.e., as “hard copies,” when a patient is being serviced by multiple health care providers Disclosed are means for electronically annotating an image associated with a patient workflow. In one implementation, there is a method that includes receiving an image via a communications network, presenting the image to a user, and capturing an annotation made to the image by the user. The annotations and the image to a medical practice management server via the communications network and the annotated image is stored as part of a patient medical record. | 07-30-2009 |
Anshul Amar, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20090313194 | METHODS AND APPARATUS FOR AUTOMATED IMAGE CLASSIFICATION - A system for automated classification of an image of an electronic document such as a facsimile document. The image is converted to a textual representation, and at least some of the terms in the textual representation may be associated with one or more predefined classification types, thereby enabling the document to be classified, and for multi-page documents, determining boundaries used to split the document into sections. The development of associations between terms and classification types may result from providing, to the system, a training set of manually-classified documents. A training module analyzes the training set to calculate probabilities that particular terms may appear in documents of a particular classification type. Probabilities established during training are used during automated document processing to assign a classification type to the document. A confidence score associated with the assigned classification type provides a metric for assessing the accuracy of the automated process. | 12-17-2009 |
Anshul Amar, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20120259654 | Predicting Out-Of-Pocket Expense for a Patient - Embodiments of computer-methods and computer systems for predicting out-of-pocket expense for a patient are disclosed. One computer-method includes obtaining claims data and provider data and grouping the claims data into priceable units. A server computes prices for each of the priceable units based on the claims data and the provider data. The priceable units are collected into bundled services as required for predicting the out-of-pocket expense of an episode. Attributes of a health plan of the patient are applied, and an out-of-pocket calculator predicts the out-of-pocket expense based on the collected priceable units and the computed prices for the collected priceable units. The out-of-pocket expense is communicated to patient through a network. | 10-11-2012 |
20120259662 | Predicting Provider Negotiated Rates - Embodiments of methods and systems for predicting provider negotiated rates are disclosed. One method includes obtaining claims data and provider data, grouping the claims data into priceable units, computing prices for each of the priceable units based on the claims data and the provider data, and estimating provider negotiated rates based on the priceable units and the computed prices for the priceable units. | 10-11-2012 |
Lauren Amar, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20140325925 | Modular Multipurpose Platform and Hardware - A multipurpose support platform system is disclosed including a variety of configurable components. In some aspects a frame is made from readily available standard materials such as construction lumber and sheet material connected by hardware support units that include metal plates securely joined in a configuration supporting the frame and sheet materials of the platform. Horizontal and vertical wall configurations are permitted, and the overall structure then allows for a secure and protective work surface for a variety of activities. | 11-06-2014 |
Levy Amar, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20140339161 | FLUID COMPONENT SEPARATION DEVICES, METHODS, AND SYSTEMS - A system for ultrafiltration employs a crossflow filtration module for extracting a fraction from a sample fluid (e.g., blood) and a recirculating permeate loop to produce a concurrent permeate flow through the filtration module to maintain a positive transmembrane pressure at all points of the crossflow filter. Permeate in the recirculating loop is enriched by a processing module and stabilized by removing an enriched fraction thereof. In an embodiment, the enriched fraction is concentrated plasma that is returned to a patient. | 11-20-2014 |
Marcele J.a. Amar, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20090270331 | MULTI-DOMAIN AMPHIPATHIC HELICAL PEPTIDES AND METHODS OF THEIR USE - Disclosed herein are peptides or peptide analogs with multiple amphipathic α-helical domains that promote lipid efflux from cells via an ABCA1-dependent pathway. Also provided herein are methods of using multi-domain amphipathic α-helical peptides or peptide analogs to treat or inhibit dyslipidemic disorders. Methods for identifying non-cytotoxic peptides that promote ABCA1-dependent lipid efflux from cells are also disclosed herein. | 10-29-2009 |
20100203099 | MULTI-DOMAIN AMPHIPATHIC HELICAL PEPTIDES AND METHODS OF THEIR USE - Disclosed herein are peptides or peptide analogs with multiple amphipathic α-helical domains that promote lipid efflux from cells via an ABCA1-dependent pathway. Also provided herein are methods of using multi-domain amphipathic α-helical peptides or peptide analogs to treat or inhibit dyslipidemic disorders. Methods for identifying non-cytotoxic peptides that promote ABCA1-dependent lipid efflux from cells are also disclosed herein. | 08-12-2010 |
Marcelo Amar, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20140213502 | CHEMICAL MODIFICATION OF APOLIPOPROTEIN MIMETIC PEPTIDES FOR THE PRODUCTION OF THERAPEUTIC AGENTS - Hydrocarbon stapling of apolipoprotein mimetic peptides increases the helicity of the peptides, enhances their ability to promote cholesterol efflux by multiple mechanisms and makes them resistant to proteolysis. Hydrocarbon stapled amphipathic helical peptides are useful in the treatment of cardiovascular diseases and other disorders. | 07-31-2014 |
Marcelo J.a. Amar, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20110033518 | PEPTIDES PROMOTING LIPID EFFLUX VIA ABCA1 AND ACTIVATING A LIPOPROTEIN LIPASE - Disclosed herein are peptides and peptide analogs with multiple amphipathic α-helical domains that promote lipid efflux from cells via an ABCA1-dependent pathway, as well as peptides that activate lipoprotein lipase, and compositions comprising such peptides or combinations thereof. Also provided herein are methods of using multi-domain amphipathic α-helical peptides or peptide analogs to treat or inhibit dyslipidemic disorders. Methods for identifying non-cytotoxic peptides that promote ABCA1-dependent lipid efflux from cells and activate lipoprotein lipase within cells are also disclosed herein. | 02-10-2011 |
20120148642 | MULTI-DOMAIN AMPHIPATHIC HELICAL PEPTIDES AND METHODS OF THEIR USE - Disclosed herein are peptides or peptide analogs with multiple amphipathic α-helical domains that promote lipid efflux from cells via an ABCA1-dependent pathway. Also provided herein are methods of using multi-domain amphipathic α-helical peptides or peptide analogs to treat or inhibit dyslipidemic disorders. Methods for identifying non-cytotoxic peptides that promote ABCA1-dependent lipid efflux from cells are also disclosed herein. | 06-14-2012 |
Michael Amar, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20120226616 | VIRTUAL GOODS INCENTIVE SYSTEM - Virtual goods, such as Facebook credits or Farmville animals, are offered as an incentive to acquire new customers or reacquire former customers. Using a simple click-through process, a customer may receive a given number of virtual credits, or a particular virtual item, upon satisfying a given requirement, such as a purchase above a given amount, a subscription to a mailing list, submission of a preference profile, and so on. Initial tests have indicated that a substantial number of customers prefer receiving such virtual items in lieu of a cash rebate or other cash-based discount, even when the actual cost associated with the virtual item is the same as, or lower than the amount of the cash-based discount. In a preferred embodiment, a third-party campaign manager facilitates the execution and management of the incentive campaign. | 09-06-2012 |
20120278247 | VIRTUAL GOODS INCENTIVE SYSTEM - An interface application enables a campaign manager to manage the transfer of virtual credits to a user upon completion of an action that benefits a provider of goods or services. The campaign manager provides a link to the provider of goods or services. When a user clicks through to this link, the interface application directs the user to perform the desired action. Upon completion of the action, the application deposits a credit to the user's virtual account. Because the virtual transaction is performed by the provided interface application, the logistics associated with launching and executing the campaign are low enough to facilitate hi-volume, low-cost incentive programs. | 11-01-2012 |
Salomon Amar, Brookline, MA US
Patent application number | Description | Published |
---|---|---|
20090062190 | Transcriptional Regulation of Cytokines by LITAF and STAT (6)(B) - The present invention relates to novel proteins (LITAF and STAT6(B)) and the nucleotide sequences encoding the same. The present invention also relates to the use of the novel peptides and nucleotide sequences of the present invention, or functional fragments thereof, for the regulation of cytokine expression. The present invention also relates to the use of the novel proteins and nucleotides sequences of the present invention for the regulation of inflammatory responses in mammals including the regulation of angiogenesis and tubulogenesis. Also in this regard, the present invention relates to the generation of null mutant animals deficient in the expression of one or both of the proteins of the present invention. | 03-05-2009 |
20090215049 | NOVEL LITAF BINDING SITE PEPTIDES AND METHODS OF USING THE SAME - The invention provides molecules containing nucleic acid sequences for fragments of LPS-induced TNF-α factor (LITAF) and vectors containing these sequences. Also provided are molecules that contain the peptide sequence SQTWREPGAAGSPFHL, or homologs thereof. Such molecules may be useful in the treatment of diseases that relate to the expression of TNF-α, where treatment involves the modulation of this expression. The invention also provides methods for identifying compounds that inhibit or enhance the transcription of TNF-α. | 08-27-2009 |
20110053849 | REGULATION OF LITAF MODULATED CYTOKINE PRODUCTION BY A NOVEL P53 SHORT PEPTIDE - The present invention relates to a novel isolated and purified peptide of the sequence KQSQHMT [SEQ ID NO: 1], nucleic acid sequences encoding said peptide sequence and capable of expressing said sequence as an exogenous protein in a target cell; as well as methods for the reduction or inhibition of LITAF activity by transfecting the peptide KQSQHMT [SEQ ID NO: 1] or a nucleic acid capable of expressing said peptide, into a target cell. The present invention also relates to the use of the novel peptide (and corresponding nucleotide sequences) of the present invention for the regulation of cytokine expression in target cells. The present invention also relates to the use of the novel peptide (and corresponding nucleotide sequences) of the present invention for the regulation of inflammatory responses in mammals. | 03-03-2011 |
20110288035 | PIMAP39 MODULATES INFLAMMATORY RESPONSE - The present invention relates to a novel peptide sequence named PIMAP39 (herein referred to as SEQ ID NO.: 1) and methods of use of the novel sequence and functional variants thereof. The present invention also relates to methods for reducing and/or modulating inflammatory responses by administration of the peptide of the present invention. Furthermore, the present invention relates to the modulation of the expression of cytokines effected as part of an inflammatory response by administration of the peptide of the present invention. | 11-24-2011 |
20130130993 | PIMAP39 MODULATES INFLAMMATORY RESPONSE - The present invention relates to a novel peptide sequence named PIMAP39 (herein referred to as SEQ ID NO.: 1) and methods of use of the novel sequence and functional variants thereof. The present invention also relates to methods for reducing and/or modulating inflammatory responses by administration of the peptide of the present invention. Furthermore, the present invention relates to the modulation of the expression of cytokines effected as part of an inflammatory response by administration of the peptide of the present invention. | 05-23-2013 |
Shaoul Amar, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20120072501 | System and Method Providing Universal Addressing in Digital Communication Systems - A system, method and computer program product providing a universal naming system. | 03-22-2012 |